| Literature DB >> 30196279 |
Hannes Maier1, Uwe Baumann2, Wolf-Dieter Baumgartner3, Dirk Beutner4, Marco D Caversaccio5, Thomas Keintzel6, Martin Kompis5, Thomas Lenarz1, Astrid Magele7, Torsten Mewes8, Alexander Müller9, Tobias Rader10, Torsten Rahne11, Sebastian P Schraven12, Burkard Schwab13, Georg Mathias Sprinzl7, Bernd Strauchmann14, Ingo Todt15, Thomas Wesarg16, Barbara Wollenberg17, Stefan K Plontke11.
Abstract
There is currently no standardized method for reporting audiological, surgical and subjective outcome measures in clinical trials with active middle ear implants (AMEIs). It is often difficult to compare studies due to data incompatibility and to perform meta-analyses across different centres is almost impossible. A committee of ENT and audiological experts from Germany, Austria and Switzerland decided to address this issue by developing new minimal standards for reporting the outcomes of AMEI clinical trials. The consensus presented here aims to provide a recommendation to enable better inter-study comparability. The Author(s). Published by S. Karger AG, Basel.Keywords: Hearing results; Active middle ear implant; Audiogram; Hearing loss; Hearing outcome ; Meta-analysis; Reporting standards; Review
Mesh：
Year: 2018 PMID： 30196279 PMCID： PMC6381865 DOI： 10.1159/000490878
Source DB: PubMed Journal: Audiol Neurootol ISSN： 1420-3030 Impact factor: 1.854